About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed DEAFNESS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ALIZAPRIDE reported DEAFNESS to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and DEAFNESS. In doing so, we compare ALIZAPRIDE with other drugs that cause DEAFNESS, to help you evaluate whether or not ALIZAPRIDE causes DEAFNESS. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if DEAFNESS ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing DEAFNESS: 2
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where DEAFNESS is a reported side effect: 1.9608%

FDA reports of any drug causing DEAFNESS : 7350
Average percentage for all medicated patients where DEAFNESS is reported as a complication: 0.0461%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with DEAFNESS:

FOSAMAX (1417 patients)
ASPIRIN (675 patients)
ZOMETA (553 patients)
VIOXX (453 patients)
AREDIA (372 patients)
LIPITOR (337 patients)
PREDNISONE (334 patients)
HUMIRA (320 patients)
NEXIUM (296 patients)
ZOLOFT (276 patients)
COUMADIN (263 patients)
SYNTHROID (244 patients)
LASIX (235 patients)
LYRICA (231 patients)
METHOTREXATE (230 patients)
PAXIL (222 patients)
FOLIC ACID (220 patients)
NEURONTIN (219 patients)
NORVASC (216 patients)
LEVAQUIN (210 patients)
REMICADE (207 patients)
PREVACID (205 patients)
SIMVASTATIN (196 patients)
DEXAMETHASONE (189 patients)
DIOVAN (188 patients)
VICODIN (184 patients)
AMBIEN (184 patients)
REVLIMID (182 patients)
AMOXICILLIN (182 patients)
HYDROCHLOROTHIAZIDE (181 patients)
ZOFRAN (180 patients)
LISINOPRIL (180 patients)
PROTONIX (178 patients)
ZOCOR (176 patients)
ATENOLOL (172 patients)
CELEBREX (170 patients)
VIAGRA (167 patients)
PRILOSEC (165 patients)
ALBUTEROL (160 patients)
FUROSEMIDE (160 patients)
TOPROL-XL (156 patients)
PLAVIX (155 patients)
XANAX (153 patients)
ATIVAN (152 patients)
DIGOXIN (151 patients)
ACETAMINOPHEN (150 patients)
OMEPRAZOLE (150 patients)
DECADRON (146 patients)
VITAMIN D (142 patients)
EXJADE (141 patients)
OXYCONTIN (137 patients)
LEXAPRO (137 patients)
SEROQUEL (135 patients)
ACCUTANE (133 patients)
PERCOCET (132 patients)
CALCIUM (131 patients)
DURAGESIC-100 (130 patients)
ZITHROMAX (130 patients)
LORAZEPAM (129 patients)
IBUPROFEN (129 patients)
COZAAR (128 patients)
CYMBALTA (128 patients)
CIPRO (128 patients)
PREMARIN (124 patients)
CRESTOR (124 patients)
ENBREL (124 patients)
ALLOPURINOL (123 patients)
CLINDAMYCIN (122 patients)
AVONEX (121 patients)
VALIUM (117 patients)
PREDNISONE TAB (115 patients)
TOPAMAX (114 patients)
ALENDRONATE SODIUM (114 patients)
PREDNISOLONE (113 patients)
LANTUS (111 patients)
CASODEX (109 patients)
WELLBUTRIN (109 patients)
ADVAIR DISKUS 100/50 (107 patients)
THALIDOMIDE (107 patients)
POTASSIUM CHLORIDE (106 patients)
AVELOX (106 patients)
OXYCODONE HCL (105 patients)
WARFARIN SODIUM (104 patients)
LEVOTHYROXINE SODIUM (103 patients)
GABAPENTIN (103 patients)
CIPROFLOXACIN (103 patients)
NITROGLYCERIN (102 patients)
COREG (102 patients)
REGLAN (101 patients)
CALCIUM (UNSPECIFIED) (100 patients)
PEGASYS (98 patients)
AZITHROMYCIN (98 patients)
LUPRON (97 patients)
FLONASE (96 patients)
FOSAMAX PLUS D (95 patients)
VITAMIN E (93 patients)
CHLORHEXIDINE GLUCONATE (93 patients)
METFORMIN HCL (92 patients)
FORTEO (91 patients)
UREA PEROXIDE (91 patients)
RADIATION THERAPY (87 patients)
MULTI-VITAMINS (87 patients)
FLOMAX (87 patients)
GLEEVEC (86 patients)
ARANESP (84 patients)
COMPAZINE (83 patients)
BONIVA (83 patients)
DILAUDID (82 patients)
METOPROLOL TARTRATE (82 patients)
CARBOPLATIN (81 patients)
FLEXERIL (81 patients)
ALLEGRA (81 patients)
HUMALOG (80 patients)
VANCOMYCIN (79 patients)
CELEXA (78 patients)
HYDROCODONE BITARTRATE (77 patients)
TYLENOL (77 patients)
LORTAB (77 patients)
DOXYCYCLINE (77 patients)
VITAMINS (UNSPECIFIED) (77 patients)
TYLENOL (CAPLET) (77 patients)
VELCADE (74 patients)
FLAGYL (73 patients)
CLONAZEPAM (72 patients)
SINGULAIR (72 patients)
TYLENOL-500 (72 patients)
HEPARIN (71 patients)
TAMOXIFEN CITRATE (70 patients)
[THERAPY UNSPECIFIED] (70 patients)
AVASTIN (69 patients)
MS CONTIN (69 patients)
CEPHALEXIN (69 patients)
KEFLEX (68 patients)
CHEMOTHERAPEUTICS NOS (68 patients)
CARDIZEM (67 patients)
CISPLATIN (67 patients)
EFFEXOR (67 patients)
ARIMIDEX (66 patients)
SPIRIVA (66 patients)
IRON (65 patients)
LAMICTAL (65 patients)
COPEGUS (65 patients)
KLONOPIN (65 patients)
PROZAC (65 patients)
VITAMIN TAB (65 patients)
DIAZEPAM (64 patients)
AVANDIA (64 patients)
ZANTAC (64 patients)
TAXOTERE (64 patients)
ELAVIL (64 patients)
BENICAR (64 patients)
ZYPREXA (63 patients)
MORPHINE (63 patients)
AMITRIPTYLINE HCL (63 patients)
TRAMADOL HCL (63 patients)
ANTIBIOTICS (63 patients)
ZYRTEC (63 patients)
ALPRAZOLAM (63 patients)
CYCLOPHOSPHAMIDE (62 patients)
ULTRAM (62 patients)
HYDROCODONE (62 patients)
ETOPOSIDE (62 patients)
TRAZODONE HCL (62 patients)
PROMETHAZINE (62 patients)
RIBAVIRIN (62 patients)
BENADRYL (61 patients)
HERCEPTIN (60 patients)
TEMAZEPAM (60 patients)
ZETIA (60 patients)
ZELNORM (60 patients)
SPIRONOLACTONE (59 patients)
MIRAPEX (59 patients)
FAMOTIDINE (59 patients)
ASCORBIC ACID (58 patients)
CHANTIX (58 patients)
CLARITIN (58 patients)
CLONIDINE (57 patients)
FENTANYL (56 patients)
BIAXIN (56 patients)
BACTRIM (55 patients)
SKELAXIN (55 patients)
NAPROXEN (55 patients)
NORCO (55 patients)
VINCRISTINE (55 patients)
TYSABRI (54 patients)
ACTONEL (54 patients)
ROCEPHIN (54 patients)
FASLODEX (54 patients)
DEMEROL (54 patients)
PREMPRO (54 patients)
GLYBURIDE (54 patients)
PERIDEX (53 patients)
AUGMENTIN '125' (53 patients)
METOPROLOL (53 patients)
LACTULOSE (53 patients)
NIASPAN (52 patients)
PROCRIT (52 patients)
NEXAVAR (52 patients)
LIDOCAINE (51 patients)
ALDACTONE (51 patients)
QUININE SULFATE (51 patients)
HYDROCORTISONE (50 patients)
FLUCONAZOLE (50 patients)
MULTI-VITAMIN (50 patients)
DARVOCET-N 100 (50 patients)
MEGACE (50 patients)
TAXOL (50 patients)
LEVITRA (49 patients)
KLOR-CON (49 patients)
DIFLUCAN (49 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about DEAFNESS and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Acton Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use